The Expanding Reach of the European Patent Office. Good for Health?
The European Patent Office (EPO) is tasked with the examination of patent applications and the granting of patents when these applications meet the patentability...
With technology transfer, 120 companies in low- and middle-income countries could manufacture mRNA vaccines
Recent reporting from the British Medical Journal (BMJ) has revealed efforts by BioNTech – the technology firm behind Pfizer’s projected $100 billion in Covid-19...
Respect for intellectual property law includes respecting the flexibilities it contains to protect the...
Thank you for the opportunity to speak. And for the latest draft of the pandemic agreementshared with us on 26 March. In particular, we...
Remdesivir developed country price announced
On 29, June 2020 Gilead announced its global price for developed countries for remdesivir, a medicine that has shown some effect in the treatment...
Fair Medicines Pricing requires addressing monopolies and increasing transparency in pharmaceutical markets
The 4th WHO Fair Pricing Forum took place from 6 - 8 February 2024. Ellen 't Hoen spoke at the opening plenary. Below are...
Cancer Drug Pricing on the World Health Organization’s Executive Board Agenda
On Thursday 24 January, the World Health Organization’s 144th Executive Board meeting will kick off in Geneva. One of the agenda items is access...
US supports the Covid-19 TRIPS Waiver for vaccines; Now, technology sharing must become a...
The United States Government announced on 5 May a bold move to drop its opposition to the proposal to waive intellectual property rights related...
Pressure from European countries related to the use of TRIPS FlexibilitiesÂ
The draft text of the World Health Organization pandemic accord reaffirms countries' rights to use to the full the flexibilities contained in the World...
Wrapping up 2019 – Noteworthy Medicines Law and Policy Events
2019 had its share of noteworthy medicines law and policy events. It was also a year that saw eye-popping new levels of pharmaceutical pricing....
Pharmaceutical patents and data exclusivity in an age of AI-driven drug discovery and development
This is an excerpt from a longer report on AI, medicines development and the patent system.
Download the full report here (or by clicking...